Your session is about to expire
← Back to Search
Influenza Vaccine Reminder Tool for Increasing Vaccination Rates
N/A
Waitlist Available
Led By Leora Horwitz, MD, MHS
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
Study Summary
This trial will test whether sending a reminder about the flu vaccine to doctors will increase the number of people who get vaccinated.
Who is the study for?
This trial is for all inpatients at NYU Langone Health who are eligible to use the Influenza clinical decision support tool. There are no specific exclusion criteria mentioned, so it appears open to these patients without restrictions.Check my eligibility
What is being tested?
The study is testing different versions of the Influenza Best Practice Alert system. The aim is to find out which version most effectively encourages healthcare providers to order influenza vaccines for their patients.See study design
What are the potential side effects?
Since this trial involves a clinical decision support tool rather than a medical treatment or drug, there aren't typical side effects associated with its use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Alert Cancelation Rate
Secondary outcome measures
Vaccination Rate at Discharge
Trial Design
2Treatment groups
Active Control
Group I: Usual CareActive Control1 Intervention
The current version of the alert will fire for this arm of the study.
Group II: Alert IterationActive Control1 Intervention
A modified version of the alert will fire for this arm of the study.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
813,845 Total Patients Enrolled
Leora Horwitz, MD, MHSPrincipal InvestigatorNYU Langone Health
5 Previous Clinical Trials
38,458 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- N/A
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Alert Iteration
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the uppermost limit of participants in this research project?
"Affirmative. Clinicaltrials.gov shows that this research is presently enrolling patients, first posted on January 16th 2018 and last amended July 13th 2022. This study needs to recruit 4000 people at a single location."
Answered by AI
Is this medical experiment actively enrolling participants?
"Affirmative. Records on clinicaltrials.gov declare that this medical trial, which was first posted on January 16th 2018, is actively recruiting participants at the moment. It aims to enroll up to 4000 patients from a single location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger